Shares of Roche Holding AG (OTCMKTS:RHHBY – Get Rating) have been assigned a consensus recommendation of “Hold” from the twelve analysts that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $193.75.
RHHBY has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft lowered Roche from a “hold” rating to a “sell” rating in a research report on Wednesday, January 18th. Barclays lowered Roche from an “overweight” rating to an “equal weight” rating in a research report on Monday, March 27th. Jefferies Financial Group lowered Roche from a “buy” rating to a “hold” rating in a research report on Wednesday, January 4th. Finally, Societe Generale upgraded Roche from a “hold” rating to a “buy” rating in a research report on Monday, February 27th.
Roche Stock Performance
OTCMKTS:RHHBY opened at $39.54 on Monday. Roche has a 12-month low of $34.70 and a 12-month high of $45.12. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.93 and a current ratio of 1.24. The business has a 50 day simple moving average of $37.04 and a 200 day simple moving average of $38.93.
Roche Increases Dividend
Institutional Trading of Roche
Several institutional investors have recently modified their holdings of RHHBY. Fisher Asset Management LLC lifted its holdings in shares of Roche by 58.6% in the third quarter. Fisher Asset Management LLC now owns 11,819,529 shares of the company’s stock valued at $485,525,000 after buying an additional 4,367,790 shares during the period. Teachers Retirement System of The State of Kentucky acquired a new stake in shares of Roche during the fourth quarter worth $14,877,000. OLD National Bancorp IN raised its position in shares of Roche by 3,411.0% during the third quarter. OLD National Bancorp IN now owns 200,972 shares of the company’s stock worth $8,255,000 after purchasing an additional 195,248 shares during the period. Todd Asset Management LLC raised its position in shares of Roche by 18.4% during the third quarter. Todd Asset Management LLC now owns 701,971 shares of the company’s stock worth $28,514,000 after purchasing an additional 109,265 shares during the period. Finally, Pacer Advisors Inc. acquired a new stake in shares of Roche during the fourth quarter worth $1,725,000. Institutional investors and hedge funds own 0.28% of the company’s stock.
About Roche
Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care.
Read More
- Get a free copy of the StockNews.com research report on Roche (RHHBY)
- Starbucks Stock Becomes a Value Play
- Kraft Heinz Recovery Gains Momentum
- Here’s Why AMD’s Weak Guidance Is A Blessing In Disguise
- BP Shares Sold Off After Earnings: Here Is What Upset Markets
- Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
